A detailed history of Castleark Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 34,989 shares of VKTX stock, worth $1.48 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
34,989
Previous 34,819 0.49%
Holding current value
$1.48 Million
Previous $1.85 Million 20.05%
% of portfolio
0.09%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$49.84 - $70.47 $8,472 - $11,979
170 Added 0.49%
34,989 $2.22 Million
Q2 2024

Aug 13, 2024

SELL
$47.39 - $80.2 $989,029 - $1.67 Million
-20,870 Reduced 37.48%
34,819 $1.85 Million
Q1 2024

May 15, 2024

BUY
$17.4 - $94.5 $968,988 - $5.26 Million
55,689 New
55,689 $4.57 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.24B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.